5-hydroxydecanoate has been researched along with Heart Failure in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levosimendan is a positive inotropic drug for the treatment of acute decompensated heart failure (HF)." | 3.81 | Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro. ( Aliabadi, A; Buchberger, E; de Martin, R; Demyanets, S; Gröger, M; Hofer-Warbinek, R; Huber, K; Kastl, SP; Kaun, C; Krychtiuk, KA; Maurer, G; Pisoni, J; Rauscher, S; Speidl, WS; Watzke, L; Wojta, J; Zuckermann, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krychtiuk, KA | 1 |
| Watzke, L | 1 |
| Kaun, C | 1 |
| Buchberger, E | 1 |
| Hofer-Warbinek, R | 1 |
| Demyanets, S | 1 |
| Pisoni, J | 1 |
| Kastl, SP | 1 |
| Rauscher, S | 1 |
| Gröger, M | 1 |
| Aliabadi, A | 1 |
| Zuckermann, A | 1 |
| Maurer, G | 1 |
| de Martin, R | 1 |
| Huber, K | 1 |
| Wojta, J | 1 |
| Speidl, WS | 1 |
1 other study available for 5-hydroxydecanoate and Heart Failure
| Article | Year |
|---|---|
Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro.
Topics: Anti-Inflammatory Agents; Cell Adhesion; Cells, Cultured; Decanoic Acids; E-Selectin; Enzyme-Linked | 2015 |